EPRX
Price
$5.81
Change
-$0.49 (-7.78%)
Updated
Jul 24 closing price
Capitalization
381.21M
11 days until earnings call
Intraday BUY SELL Signals
MIST
Price
$1.16
Change
-$0.04 (-3.33%)
Updated
Jul 24 closing price
Capitalization
144.42M
16 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

EPRX vs MIST

EPRX vs MIST Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
EPRX vs. MIST commentary
Jul 27, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EPRX is a StrongBuy and MIST is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 27, 2026
Stock price -- (EPRX: $5.81 vs. MIST: $1.16)
Brand notoriety: EPRX and MIST are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: EPRX: 146% vs. MIST: 54%
Market capitalization -- EPRX: $381.21M vs. MIST: $144.42M
EPRX [@Biotechnology] is valued at $381.21M. MIST’s [@Biotechnology] market capitalization is $144.42M. The market cap for tickers in the [@Biotechnology] industry ranges from $121.16B to $0. The average market capitalization across the [@Biotechnology] industry is $2.09B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

EPRX’s FA Score shows that 1 FA rating(s) are green whileMIST’s FA Score has 0 green FA rating(s).

  • EPRX’s FA Score: 1 green, 4 red.
  • MIST’s FA Score: 0 green, 5 red.
According to our system of comparison, EPRX is a better buy in the long-term than MIST.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

EPRX’s TA Score shows that 4 TA indicator(s) are bullish while MIST’s TA Score has 2 bullish TA indicator(s).

  • EPRX’s TA Score: 4 bullish, 5 bearish.
  • MIST’s TA Score: 2 bullish, 4 bearish.
According to our system of comparison, EPRX is a better buy in the short-term than MIST.

Price Growth

EPRX (@Biotechnology) experienced а -11.84% price change this week, while MIST (@Biotechnology) price change was -2.11% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -4.78%. For the same industry, the average monthly price growth was -3.76%, and the average quarterly price growth was +1901.89%.

Reported Earning Dates

EPRX is expected to report earnings on Aug 07, 2026.

MIST is expected to report earnings on Aug 12, 2026.

Industries' Descriptions

@Biotechnology (-4.78% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
EPRX($381M) has a higher market cap than MIST($144M). EPRX YTD gains are higher at: -23.046 vs. MIST (-42.574). EPRX has higher annual earnings (EBITDA): -47.14M vs. MIST (-54.13M). MIST has more cash in the bank: 184M vs. EPRX (139M). EPRX has less debt than MIST: EPRX (2.01M) vs MIST (59.2M). EPRX (0) and MIST (0) have equivalent revenues.
EPRXMISTEPRX / MIST
Capitalization381M144M265%
EBITDA-47.14M-54.13M87%
Gain YTD-23.046-42.57454%
P/E RatioN/AN/A-
Revenue00-
Total Cash139M184M76%
Total Debt2.01M59.2M3%
FUNDAMENTALS RATINGS
MIST: Fundamental Ratings
MIST
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
41
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
81
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
EPRXMIST
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 4 days ago
69%
Bullish Trend 4 days ago
90%
Momentum
ODDS (%)
Bearish Trend 4 days ago
77%
Bearish Trend 4 days ago
90%
MACD
ODDS (%)
Bearish Trend 4 days ago
68%
Bearish Trend 4 days ago
82%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
69%
Bearish Trend 4 days ago
83%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
60%
Bearish Trend 4 days ago
84%
Advances
ODDS (%)
Bullish Trend 6 days ago
79%
N/A
Declines
ODDS (%)
Bearish Trend 4 days ago
74%
Bearish Trend 8 days ago
82%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
76%
Bullish Trend 4 days ago
79%
Aroon
ODDS (%)
Bullish Trend 4 days ago
71%
Bearish Trend 4 days ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
EPRX
Daily Signal:
Gain/Loss:
MIST
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PSECX19.930.28
+1.42%
1789 Growth and Income C
JVASX41.180.43
+1.06%
JPMorgan Value Advantage I
MOSLX9.150.07
+0.77%
MassMutual Overseas Adm
VCIEX10.350.05
+0.49%
VALIC Company I International Eqs Idx
HGHYX51.490.21
+0.41%
Hartford Healthcare Y

EPRX and

Correlation & Price change

A.I.dvisor tells us that EPRX and LCTX have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that EPRX and LCTX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EPRX
1D Price
Change %
EPRX100%
-7.78%
LCTX - EPRX
32%
Poorly correlated
-3.74%
NAGE - EPRX
32%
Poorly correlated
+0.63%
MIST - EPRX
29%
Poorly correlated
-3.33%
NTLA - EPRX
29%
Poorly correlated
-3.33%
IMNM - EPRX
29%
Poorly correlated
+0.91%
More

MIST and

Correlation & Price change

A.I.dvisor indicates that over the last year, MIST has been loosely correlated with JBIO. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if MIST jumps, then JBIO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MIST
1D Price
Change %
MIST100%
-3.33%
JBIO - MIST
36%
Loosely correlated
+2.34%
TNYA - MIST
36%
Loosely correlated
+0.25%
TSHA - MIST
36%
Loosely correlated
-5.32%
RXRX - MIST
36%
Loosely correlated
-1.66%
BCYC - MIST
34%
Loosely correlated
-6.97%
More